{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:34:44Z","timestamp":1767990884214,"version":"3.49.0"},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with high on-treatment platelet reactivity (HTPR) undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) face increased risks of major adverse cardiovascular events (MACEs). Although platelet function tests like thrombelastography (TEG), vasodilator-stimulated phosphoprotein (VASP), PL-11, and VerifyNow have been described, the correlation between them and their prognostic implications remains uncertain. This prospective study aims to evaluate the consistency and effectiveness of four platelet function detection methods in predicting long-term MACEs in patients with ACS. All 98 ACS patients undergoing PCI with clopidogrel were assessed for HTPR using four platelet function detection methods. The endpoint was the occurrence of MACEs, including cardiac death, nonfatal myocardial infarction (MI), and target vessel revascularization (TVR). Among 98 patients enrolled from April 1, 2014 to June 30, 2014, 27 (27.6%) patients with VerifyNow-detected HTPR (P2Y12 reaction units [PRUs] &gt;240). The incidence of HTPR was 58.2% for TEG, 52% for VASP, and 13.3% for PL-11. VerifyNow and TEG showed the highest consistency in detecting HTPR (kappa\u2009=\u20090.201, p\u2009=\u20090.015). During a median follow-up of 6.1 years, 29 MACEs occurred, including 24 TVRs, 3 cardiovascular deaths, and 2 nonfatal MIs. VerifyNow-detected HTPR independently predicted long-term MACEs (hazard ratio: 5.73, 95% confidence interval: 2.04\u201316.09, p\u2009=\u20090.001), even after adjusting for traditional risk factors (TRFs). Receiver operating characteristic (ROC) analysis indicated that the model incorporating TRFs and VerifyNow-detected HTPR had superior predictive discrimination for MACEs (area under ROC curve\u2009=\u20090.889). VerifyNow-detected HTPR independently emerges as a robust predictor for long-term MACEs, demonstrating superior predictive discrimination compared with other platelet function tests.<\/jats:p>","DOI":"10.1055\/a-2570-4538","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:20:26Z","timestamp":1745608826000},"page":"941-949","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions"],"prefix":"10.1055","volume":"51","author":[{"given":"Mingyao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"},{"name":"Department of Cardiology, General Hospital of the PLA Central Theater Command, Wuhan, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changhai Hospital, Shanghai, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"M S Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison","volume":"72","author":"D Capodanno","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"J P Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","article-title":"Pharmacogenetics to guide cardiovascular drug therapy","volume":"18","author":"J D Duarte","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/CM9.0000000000000210","article-title":"Clinical outcomes and predictive model of platelet reactivity to clopidogrel after acute ischemic vascular events","volume":"132","author":"Q Ma","year":"2019","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"G Parodi","year":"2011","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"G W Stone","year":"2013","journal-title":"Lancet"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"D Sibbing","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"ref9","first-page":"103964","article-title":"Does individualized guided selection of antiplatelet therapy improve outcomes after percutaneous coronary intervention? A systematic review and meta-analysis","volume":"79","author":"N Yamani","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pharmtox-051921-092701","article-title":"Pharmacogenetics of antiplatelet therapy","volume":"63","author":"M Castrichini","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/09537104.2011.579648","article-title":"Genetic determinants of on-clopidogrel high platelet reactivity","volume":"22","author":"G Campo","year":"2011","journal-title":"Platelets"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.2011.03955.x","article-title":"Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations","volume":"72","author":"N Sambu","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"S 03","key":"ref13","doi-asserted-by":"crossref","first-page":"20A","DOI":"10.1016\/j.amjcard.2008.11.019","article-title":"Methods for the measurement of platelet function","volume":"103","author":"A D Michelson","year":"2009","journal-title":"Am J Cardiol"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1055\/s-0041-1728786","article-title":"The current role of platelet function testing in clinical practice","volume":"47","author":"G A Mason","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"N J Breet","year":"2010","journal-title":"JAMA"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09537104.2013.865835","article-title":"Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals","volume":"26","author":"J Guan","year":"2015","journal-title":"Platelets"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"14","author":"F J Neumann","year":"2019","journal-title":"EuroIntervention"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1213\/ANE.0000000000003310","article-title":"Implication of major adverse postoperative events and myocardial injury on disability and survival: a planned subanalysis of the ENIGMA-II trial","volume":"127","author":"W S Beattie","year":"2018","journal-title":"Anesth Analg"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"R Marcucci","year":"2009","journal-title":"Circulation"},{"issue":"03","key":"ref20","first-page":"e23139","article-title":"Target vessel versus complete revascularization in non-ST elevation myocardial infarction without cardiogenic shock","volume":"14","author":"N Pandit","year":"2022","journal-title":"Cureus"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","article-title":"Current concepts and novel targets for antiplatelet therapy","volume":"20","author":"M Gawaz","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-2517-9_1","article-title":"Coronary artery disease: from mechanism to clinical practice","volume":"1177","author":"C Shao","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jth.13997","article-title":"Platelet function testing: dead or alive","volume":"16","author":"C Helten","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2017.02.006","article-title":"Comparison of Multiplate and VerifyNow platelet function tests in predicting clinical outcome in patients with acute coronary syndromes","volume":"152","author":"P D Larsen","year":"2017","journal-title":"Thromb Res"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4103\/0366-6999.152611","article-title":"Comparing of light transmittance aggregometry and modified thrombelastograph in predicting clinical outcomes in Chinese patients undergoing coronary stenting with clopidogrel","volume":"128","author":"X F Tang","year":"2015","journal-title":"Chin Med J (Engl)"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/bcpt.13429","article-title":"Predicting ischaemic events using platelet reactivity in patients receiving clopidogrel: indirect meta-comparison among VerifyNow, light transmission aggregometry and thromboelastography","volume":"127","author":"Q Xiang","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2570-4538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:53:00Z","timestamp":1760568780000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2570-4538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":26,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2570-4538","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}